Chemotherapy of disseminated seminoma

Lawrence Einhorn, S. D. Williams

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Nineteen patients with disseminated seminoma were treated with platinum + vinblastine + bleomycin + adriamycin. All patients have been followed for at least 1 year. Nine patients had elevated HCG and two also had elevated AFP. Twelve of 19 patients (63%) achieved a complete remission, with a median duration of 18 months, and none of these patients have relapsed. Four of these patients have been in a continuous complete remission for over 2 years. The results of chemotherapy in metastatic seminoma are comparable to those achieved in nonseminomatous germ-cell tumors, and similar treatment strategies should be employed.

Original languageEnglish
Pages (from-to)307-313
Number of pages7
JournalCancer Clinical Trials
Volume3
Issue number4
StatePublished - 1980

Fingerprint

Seminoma
Drug Therapy
Vinblastine
Bleomycin
Platinum
Doxorubicin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Einhorn, L., & Williams, S. D. (1980). Chemotherapy of disseminated seminoma. Cancer Clinical Trials, 3(4), 307-313.

Chemotherapy of disseminated seminoma. / Einhorn, Lawrence; Williams, S. D.

In: Cancer Clinical Trials, Vol. 3, No. 4, 1980, p. 307-313.

Research output: Contribution to journalArticle

Einhorn, L & Williams, SD 1980, 'Chemotherapy of disseminated seminoma', Cancer Clinical Trials, vol. 3, no. 4, pp. 307-313.
Einhorn, Lawrence ; Williams, S. D. / Chemotherapy of disseminated seminoma. In: Cancer Clinical Trials. 1980 ; Vol. 3, No. 4. pp. 307-313.
@article{d1f53298918b4b10996ae85405dfc990,
title = "Chemotherapy of disseminated seminoma",
abstract = "Nineteen patients with disseminated seminoma were treated with platinum + vinblastine + bleomycin + adriamycin. All patients have been followed for at least 1 year. Nine patients had elevated HCG and two also had elevated AFP. Twelve of 19 patients (63{\%}) achieved a complete remission, with a median duration of 18 months, and none of these patients have relapsed. Four of these patients have been in a continuous complete remission for over 2 years. The results of chemotherapy in metastatic seminoma are comparable to those achieved in nonseminomatous germ-cell tumors, and similar treatment strategies should be employed.",
author = "Lawrence Einhorn and Williams, {S. D.}",
year = "1980",
language = "English",
volume = "3",
pages = "307--313",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Chemotherapy of disseminated seminoma

AU - Einhorn, Lawrence

AU - Williams, S. D.

PY - 1980

Y1 - 1980

N2 - Nineteen patients with disseminated seminoma were treated with platinum + vinblastine + bleomycin + adriamycin. All patients have been followed for at least 1 year. Nine patients had elevated HCG and two also had elevated AFP. Twelve of 19 patients (63%) achieved a complete remission, with a median duration of 18 months, and none of these patients have relapsed. Four of these patients have been in a continuous complete remission for over 2 years. The results of chemotherapy in metastatic seminoma are comparable to those achieved in nonseminomatous germ-cell tumors, and similar treatment strategies should be employed.

AB - Nineteen patients with disseminated seminoma were treated with platinum + vinblastine + bleomycin + adriamycin. All patients have been followed for at least 1 year. Nine patients had elevated HCG and two also had elevated AFP. Twelve of 19 patients (63%) achieved a complete remission, with a median duration of 18 months, and none of these patients have relapsed. Four of these patients have been in a continuous complete remission for over 2 years. The results of chemotherapy in metastatic seminoma are comparable to those achieved in nonseminomatous germ-cell tumors, and similar treatment strategies should be employed.

UR - http://www.scopus.com/inward/record.url?scp=0019126717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019126717&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 307

EP - 313

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 4

ER -